Diabetes treatment is constantly advancing, with new therapeutic options developing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://zaynrvss562415.wikiitemization.com/5559367/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment